{
    "pmcid": "11702703",
    "qa_pairs": {
        "How can Disobind's predictions be utilized in molecular dynamics simulations?": [
            "They can explore the dynamic behavior of IDR-mediated interactions and provide insights into SARS-CoV-2 spike protein binding.",
            "They are used to predict the static structure of protein complexes.",
            "They eliminate the need for simulations by providing complete interaction maps.",
            "They are only applicable to structured protein regions, not IDRs."
        ],
        "How does the combination of Disobind and AlphaFold-Multimer improve the prediction of IDR binding sites?": [
            "It enhances the accuracy of identifying IDR binding sites by leveraging both methods' strengths.",
            "It reduces the computational time needed for predictions.",
            "It increases the sequence conservation of IDRs.",
            "It eliminates the need for protein language models."
        ],
        "What is the main advantage of Disobind over AlphaFold-Multimer in predicting interactions involving intrinsically disordered regions (IDRs)?": [
            "Disobind predicts inter-protein contact maps and interface residues without relying on structural data or MSAs.",
            "Disobind uses a higher confidence cutoff for predictions than AlphaFold-Multimer.",
            "Disobind requires less computational power than AlphaFold-Multimer.",
            "Disobind is specifically designed for structured protein complexes, unlike AlphaFold-Multimer."
        ],
        "What role do protein language models (pLMs) play in Disobind's prediction process?": [
            "They capture the context of the binding partner, crucial for understanding IDR interactions.",
            "They provide structural data for IDR predictions.",
            "They increase the sequence conservation of IDRs.",
            "They are used to lower the confidence cutoff for predictions."
        ],
        "Why is accurately predicting IDR interactions important for designing nanobodies against the SARS-CoV-2 spike protein?": [
            "The spike protein contains disordered regions that are potential targets for therapeutic intervention.",
            "IDR interactions are not relevant for the SARS-CoV-2 spike protein.",
            "Nanobodies do not interact with disordered regions of proteins.",
            "The spike protein is entirely structured and does not contain IDRs."
        ]
    }
}